Skip to main content
. 2018 Feb 16;43(2):272–281. doi: 10.1016/j.jgr.2018.02.006

Fig. 8.

Fig. 8

Expression of PEPCK, TRPV1, and TrkA in AIDN zebrafish (##p < 0.01; compared to normal, **p < 0.01, ***p < 0.001; compared to alloxan treatment). (A) PEPCK expression. (B) TRPV1 expression. (C) TrkA expression.

AIDN, alloxan-induced diabetic neuromast; PEPCK, phosphoenolpyruvate carboxykinase; TRPV1, transient receptor potential channel vanilloid subfamily type 1; TrkA, topomyosin receptor kinase A.